Circulation · 1991 · 608 citations · 17 references
MedicineCardiologySurgeryCardiothoracic SurgeryClinical CardiologyInterventional CardiologyBalloon AngioplastyCoronary AngioplastyCoronary Artery SurgeryMyocardial Infarction ComplicationsPercutaneous Coronary InterventionStent PlacementAngioplasty ComplicationsBalloon-expandable StentsClinical Outcomes After Percutaneous Coronary InterventionComplications Of Stent PlacementCoronary Balloon AngioplastyCoronary StentingElective Percutaneous Coronary InterventionStent-assisted Angioplasty
Stenting of native coronary arteries with a balloon-expandable stent was attempted in 226 patients after elective angioplasty. Delivery of the device was successful in 213 (94%) of the patients. Of these, 39 received aspirin and dipyridamole only (group 1) and 174 received aspirin, dipyridamole, and warfarin for 1-3 months (group 2). There was no abrupt closure (less than or equal to 1 day) or perioperative death in either group. In-hospital or perioperative complications in group 1 compared with group 2 were as follows: subacute closure (1-14 days), seven (18%) patients versus one (0.6%) patient, respectively, p less than 0.0001; myocardial infarction, five (13%) patients versus one (0.6%) patient, respectively; condition requiring urgent bypass surgery, one (2.5%) patient versus no patients, respectively. Thus, the incidence of major complications such as death, myocardial infarction, or a condition requiring urgent bypass surgery was 15% in group 1 and 0.6% in group 2. Clinical follow-up revealed that 92% of the patients were asymptomatic at 3 months after stenting compared with 6% before stenting (p less than 0.0001). Of the 13 patients who were symptomatic, nine underwent cardiac catheterization and, ultimately, successful elective coronary angioplasty or bypass surgery. We conclude that a high delivery success rate can be expected with this device and that clinical thrombosis is less frequent in anticoagulated patients than in nonanticoagulated patients. Furthermore, in this selected patient population, coronary stenting results in a low incidence of in-hospital and perioperative complications. Clinical success, defined by absence of symptoms, appears to be sustained at 3 months.
17
Intravascular Stents to Prevent Occlusion and Re-Stenosis after Transluminal Angioplasty
Ulrich Sigwart, V. Mirkovitch, F. Joffre et al. · New England Journal of Medicine · 1987 · 1.9K citations
Medicine, Cardiology, Surgery +17
Transluminal Treatment of Arteriosclerotic Obstruction
Charles T. Dotter, Melvin P. Judkins · Circulation · 1964 · 1.8K citations · Full text
David R. Holmes, Ronald E. Vlietstra, Hugh C. Smith et al. · The American Journal of Cardiology · 1984 · 1.1K citations
Medicine, Cardiology, Surgery +13
Percutaneous Transluminal Coronary Angioplasty in 1985–1986 and 1977–1981
Katherine M. Detre, Richard Holubkov, Sheryl F. Kelsey et al. · New England Journal of Medicine · 1988 · 855 citations
Medicine, Cardiology, Surgery +14
Transluminally-placed Coilspring Endarterial Tube Grafts
Charles T. Dotter · Investigative Radiology · 1969 · 658 citations
Medicine, Neurosurgery, Surgery +8